This brings a whole new meaning to Black Friday. Thankfully we are closed.
T
Today's Markets are brought to you by, "New coronavirus variant in South Africa".
b
Glad I bought ISPC on Wednesday! WOW!
n
OUCH! Back under $36 we go. We will close around $35 ish
B
I have an order set for $34.50
C
I admit, the ICEMAN has been impressive since October 11th, by keeping this stock under $40, that's a long time and we had an ER during that time. I'm still holding a core position here and think sometime in January it will rise more if we get an EU approval, which we should. I took my profits elsewhere for this Santa Rally Season. I hope everyone here has a great Thanksgiving!
E
ICEMAN!
B
Hey Chewdog, I just checked Nasdaq after hours volume for CCXI, ONLY 4,528 traded, that green means nothing. ICEMAN strikes again.
R
Not so bad as it seemed to be at pre-mkt... maybe we end the day above 39.
S
This is going to keep getting played with until EU approval and earnings or some kind of status update on one of thier other drugs ..
T
It's best to simply day trade until January. Buy low and sell high. In fact, sell anything over $40 and buy anything under $39. Easy, this has been the same pattern for the last 6 weeks.
N
strong like BULL, that is why i never pay too much attention to pre-market and after market prices.
S
If your losing money in the market today and have not been vaccinated.. Thank Your Self for the money your losing and don't cry about it
S
Awfully something they announce this the day after Thanksgiving.. I guess they didn't know anything about this Covid variant until yesterday lol
A
Can someone explain who Iceman is and how he controls our investment and the ccxi stock price. TY
E
The ICEMAN strikes again. We haven't closed over $40 in almost 2 months, even after great earnings.
S
Buy order in again at 38.00
T
ICEMAN has struck again! I thought that he would be on vacation this week.
E
Listened to the Stifel and Piper Sandler conference calls with Schall. Confirmed that EU approval is merely an administrative process now and $45 million will be payable from Vifor for milestone fees.
Big point to acknowledge is that 9500 patients in the US are of severe condition and undoubtedly in need of intervention. However, the second 10,200 group of active ANCA associated vasculitis are fluctuating and their treatment is subject to physician discretion. This is a notable difference to what was being said in earlier conferences that restrained the market potential to the 9500 patient figure. Schall admitted they’re researching and learning more about the market as they enter commercialisation. Also very positive tone on US launch despite Covid restrictions/upcoming holidays. Reaffirmed that royalties from EU/Japan sales will be a top-line contribution of high teens - mid twenties in percentage to CCXI.
January earnings report could be huge for all these reasons (especially if approval comes before earnings). I do expect commercial operations expenses to increase though so not sure if EPS will report a beat. Holding strong through this horrible market.
Big point to acknowledge is that 9500 patients in the US are of severe condition and undoubtedly in need of intervention. However, the second 10,200 group of active ANCA associated vasculitis are fluctuating and their treatment is subject to physician discretion. This is a notable difference to what was being said in earlier conferences that restrained the market potential to the 9500 patient figure. Schall admitted they’re researching and learning more about the market as they enter commercialisation. Also very positive tone on US launch despite Covid restrictions/upcoming holidays. Reaffirmed that royalties from EU/Japan sales will be a top-line contribution of high teens - mid twenties in percentage to CCXI.
January earnings report could be huge for all these reasons (especially if approval comes before earnings). I do expect commercial operations expenses to increase though so not sure if EPS will report a beat. Holding strong through this horrible market.